Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
Zanchetti
A
A
Istituto di Clinica Medica Generale e Terapia Medica, Università di Milano, Ospedale Maggiore, Milan, Italy.
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D004095:Dihydropyridines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004095:Dihydropyridines; C060285:lacidipine